Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
about
G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanismsTargeting G protein coupled receptor-related pathways as emerging molecular therapiesFinding a better path to drug selectivityTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyParoxetine Is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial ContractilityStructural and Functional Analysis of G Protein-Coupled Receptor Kinase Inhibition by Paroxetine and a Rationally Designed AnalogMolecular Mechanism for Inhibition of G Protein-Coupled Receptor Kinase 2 by a Selective RNA AptamerEthanol effects on glycinergic transmission: From molecular pharmacology to behavior responsesEndothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.Evidence for α-helices in the large intracellular domain mediating modulation of the α1-glycine receptor by ethanol and Gβγ.Molecular basis for small molecule inhibition of G protein-coupled receptor kinasesG protein βγ subunits regulate cardiomyocyte hypertrophy through a perinuclear Golgi phosphatidylinositol 4-phosphate hydrolysis pathway.Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitorG protein-coupled receptor kinases: more than just kinases and not only for GPCRsSuppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and InternalizationCrystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed InhibitorStructure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors.Substrate-induced changes in the dynamics of rhodopsin kinase (G protein-coupled receptor kinase 1).Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway.Structural insights into G protein-coupled receptor kinase function.Beyond traditional pharmacology: new tools and approaches.Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility.Endothelial Dysfunction in Obesity.Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.G protein-coupled receptors control the sensitivity of cells to the morphogen Sonic Hedgehog.The Role of G Protein-coupled Receptor Kinases in Cancer.The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
P2860
Q26786233-99673BDC-599C-4421-AA7F-7DCD81034E47Q26829964-8E7C5365-F576-4B7A-9A98-E78083031064Q27008204-2834EE93-1511-41F0-BA88-1EA947F2A63BQ27024879-721D19A9-75F5-4D8A-811D-0EDDCFF697DCQ27671474-7E16C907-5DEB-4230-ACCF-8CE1FA8E5AC4Q27680587-1D8737DB-BDE4-4471-86FE-561407D2932BQ27681349-68DF56B2-F3E1-4DB4-AD95-46B2D0D055B9Q30371246-0568DA0B-1384-40CF-8D26-741CD6E441A8Q33931244-0D950731-26AC-45B5-8F47-ADD16F62D1F5Q34076059-C33712BA-2480-470D-BAC3-EDECA8C25B56Q34785588-4DF7471D-61A4-4567-BB89-B471639FC13EQ34992803-4E62E007-74A7-4217-BF25-67DB1CEA2451Q35171028-4C25EA46-A761-4400-8C25-C6AA7A81F003Q35360619-03480449-F7AB-4BFA-ACDC-5222196260EFQ35621624-839C9E78-A13E-4BBA-A5BF-758FB394DE1CQ35683150-42B007B2-E192-4AB1-A520-A494870B0D32Q35897872-D21CCE3D-FE03-4FF6-BD39-3A25BD8BDD88Q35978165-2C75302E-2FE1-4BA4-9C2C-5CE3E13C499FQ35981205-B39C3143-1AAB-435A-BC6A-9C6C925F3CBBQ36173913-134C2759-5210-4B99-AC23-1ECBF2B25E7AQ36316194-4E1E939F-39E2-48AB-B31C-9DEB8C29633EQ36685199-BE4D95AB-9897-491D-90BC-B4DB0599FDE8Q37676935-8D251731-8C9A-4236-AECA-CBDA60FF6A60Q38311702-1110058C-BE18-4C8B-9280-1182521E7C4FQ39345564-A0290265-FAC0-4C14-8D82-AB518EE72243Q42781808-BEA22AE2-7D57-4221-BB26-3E78360FC62EQ46355665-2362882D-D6E3-4293-91C2-38EBC1C7F291Q47603118-81337F79-BBE7-436B-9CC3-582F554518A3Q50042900-9997A649-02C4-427A-9B4F-15434A73DCB9Q50285621-18760DD4-F86F-465A-8C65-1FE05BC90DF5Q52688913-60B20BEA-0A3D-4B65-9898-7B2F6A681E97
P2860
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@ast
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@en
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@nl
type
label
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@ast
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@en
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@nl
prefLabel
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@ast
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@en
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@nl
P2093
P2860
P356
P1476
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
@en
P2093
Christian Schoenau
David M Thal
Jochen Huber
John J G Tesmer
Raymond Y Yeow
P2860
P304
P356
10.1124/MOL.111.071522
P577
2011-08-01T00:00:00Z